Summary & Overview
CPT 92601: Diagnostic Analysis of Cochlear Implant for Patients Under 7
CPT code 92601 represents the diagnostic analysis of cochlear implants for patients younger than 7 years of age, a vital service in pediatric otolaryngology and audiology. This procedure is essential for evaluating the performance and function of cochlear implants, ensuring that young children with hearing loss receive optimal auditory outcomes. The code is widely recognized and reimbursed by major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare.
This publication provides a comprehensive overview of 92601, including its clinical context, typical site of service, and its role in the broader landscape of evaluative and therapeutic otorhinolaryngologic services. Readers will gain insights into payer coverage, relevant benchmarks, and policy updates affecting the use of this code. The summary also highlights the importance of accurate diagnostic analysis in pediatric cochlear implant management, as well as the associated clinical and billing considerations. By understanding the scope and application of 92601, stakeholders can better navigate the complexities of medical billing and reimbursement for cochlear implant services in young children.
CPT Code Overview
CPT code 92601 is used for the diagnostic analysis of cochlear implants in patients younger than 7 years of age. This procedure falls under Evaluative and Therapeutic Otorhinolaryngologic Services and is typically performed in an office setting (Place of Service 11). The service involves assessing the function and performance of a cochlear implant, which is critical for ensuring optimal hearing outcomes in pediatric patients. Accurate diagnostic analysis helps guide further management and programming of the implant, supporting the ongoing care of children with hearing loss.
Clinical & Coding Specifications
Clinical Context
A child under 7 years of age with a cochlear implant presents to the office for a scheduled diagnostic analysis. The patient may have a history of sensorineural hearing loss and has previously undergone cochlear implantation. During the visit, the provider—typically an audiologist or otolaryngologist—performs a comprehensive evaluation of the implant's function, including device integrity, mapping, and auditory response. This assessment helps determine if the implant is functioning optimally and guides any necessary adjustments or further interventions.
Coding Specifications
-
Modifier
52(Reduced Services): Used when the diagnostic analysis of the cochlear implant is performed but not all elements of the service are completed, such as when the patient is unable to tolerate the full procedure. -
Modifier
76(Repeat Procedure by Same Physician): Used when the diagnostic analysis is repeated by the same provider, for example, if a follow-up analysis is required within a short period.
| Provider Taxonomy Code | Specialty Name |
|---|---|
207Y00000X | Otolaryngology Physician |
237600000X | Audiologist |
207YX0602X | Otolaryngology/Facial Plastic Surgery |
Related Diagnoses
-
H90.3- Sensorineural hearing loss, bilateral- Indicates the patient has hearing loss affecting both ears, commonly leading to cochlear implantation.
-
H91.90- Unspecified hearing loss, unspecified ear- Used when hearing loss is present but not specified by ear or type; may be relevant for initial evaluation.
-
Z96.21- Cochlear implant status- Denotes the presence of a cochlear implant, directly relevant to the procedure.
-
H91.93- Unspecified hearing loss, bilateral- Indicates bilateral hearing loss without further specification; supports the need for cochlear implant analysis.
-
H90.5- Unspecified sensorineural hearing loss- Used when sensorineural hearing loss is diagnosed but not further specified; relevant for patients with cochlear implants.
Related CPT Codes
-
92602- Reprogramming of cochlear implant, patient younger than 7 years- Used when adjustments to the implant's programming are required after diagnostic analysis. Often performed in conjunction with
92601.
- Used when adjustments to the implant's programming are required after diagnostic analysis. Often performed in conjunction with
-
92603- Diagnostic analysis of cochlear implant, patient age 7 years or older; with programming- Similar to
92601but for patients aged 7 years or older. Used as an alternative based on patient age.
- Similar to
-
92604- Reprogramming of cochlear implant, patient age 7 years or older- Used for programming adjustments in older patients, often following diagnostic analysis with
92603.
- Used for programming adjustments in older patients, often following diagnostic analysis with
-
92557- Comprehensive audiometry threshold evaluation and speech recognition- May be performed alongside cochlear implant analysis to assess hearing thresholds and speech recognition abilities.
National Reimbursement Benchmarks
For CPT code 92601, the national mean rate for Medicare is $160.02, while the BUCA (average commercial) mean rate is $199.23. Commercial payers such as UnitedHealth Group and Cigna report higher mean rates, with UnitedHealth Group at $249.34 and Cigna at $235.58, compared to Medicare.
Rate dispersion varies significantly across payers. Medicare shows the tightest range between the 75th and 25th percentiles ($13.00), indicating relatively consistent reimbursement. In contrast, UnitedHealth Group exhibits the widest dispersion ($147.10), followed by Cigna ($130.00), reflecting greater variability in commercial rates. Aetna and Blue Cross Blue Shield have moderate ranges of $54.00 and $71.95, respectively.
The table and chart below present the full breakdown of national benchmarks for CPT code 92601 by payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.